P16.28: COVID 19 Outcomes in Hospitalized Kidney and Kidney/Pancreas Transplant Recipients During Omicron Variant Wave

Le résumé fourni par la source

A Total of 49 kidney and kidney pancreas transplant recipients were hospitalized with COVID 19 between December 2021 and February 2022. Mean age of patients was 51 years, 21 were females (42.8%) and 28 were males (57.1%). 24 patients (48.9%) were Hispanic, 23 patients (46.9%) were African American, 1 patient (2%) was Asian and 1 patient (2%) was Caucasian. 14 patients (8.1%) were within one year post transplantation. 28 of patients (57.1%) required oxygen therapy, 13 patients (26.5%) were admitted to intensive care unit and 10 patients died (20.4%). 22 patients were fully vaccinated against covid 19 (44.9%), 19 (38.7%) were partially vaccinated and 8 (16.3%) were unvaccinated. Among the unvaccinated group 5 (63%) required oxygen therapy, 2 (25%) patients admitted to the intensive care unit and susequently died. Among the partially vaccinated group 12 (63%) required oxygen, 8 (42%) admitted to intensive care unit and 6 (32%) died. 2 of unvaccinated patients were admitted to ICU for hyperglycemia management rather than COVID 19 related symptoms. In fully vaccinated group 11 patients (50%) required oxygen therapy, 3 (14%) admitted to the ICU and 2 died (9%). one of the fully vaccinated patient was admitted to the ICU for hyperglycemia management. See Table 1. Vaccination against COVID 19 may reduce severity and mortality rate in kidney and kidney/pancreas transplant recipients.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.